What are the clinical features, diagnostic work‑up, treatment options, and prognosis for benign Rolandic epilepsy (self‑limited focal epilepsy of childhood) in children?

Benign Rolandic Epilepsy (Self-Limited Focal Epilepsy with Centrotemporal Spikes)

Benign Rolandic epilepsy is a self-limited childhood epilepsy syndrome that typically does not require neuroimaging when clinical and EEG features are characteristic, and treatment decisions should prioritize the fact that many children have excellent seizure control and spontaneous remission in adolescence. 1

Clinical Features

Benign Rolandic epilepsy presents with highly stereotyped characteristics that allow clinical diagnosis:

• Age of onset: After 2 years, typically between 3-13 years 2
• Seizure semiology: Brief focal seizures involving the face and mouth (hemifacial sensory-motor symptoms, hypersalivation, speech arrest)
• Timing: Frequent nocturnal occurrence, often awakening the child from sleep 2
• Neurological status: Normal neurologic examination and intellectual function between seizures 2
• Family history: Often positive for epilepsy, reflecting genetic influences 2

Important Caveats on "Benign" Nature

The term "benign" is misleading and no longer recommended 3. While seizure prognosis is excellent, cognitive and behavioral comorbidities are increasingly recognized:

• Mild language impairment, attention deficit hyperactivity disorder, and behavioral problems occur in both typical and atypical presentations 4, 5
• These neuropsychological difficulties should not be dismissed as they affect quality of life 6
• Language dysfunction involves semantic functions and discourse, independent of recent epileptic activity 5

Diagnostic Work-Up

EEG Findings

• Characteristic pattern: Centrotemporal spikes with distinctive morphology superimposed on normal background activity 2
• Sleep activation of epileptiform discharges is typical 7

Neuroimaging Recommendations

Several seizure syndromes (including benign rolandic seizures) with characteristic clinical or EEG findings usually do not require imaging 1.

Imaging is indicated only when:

• Clinical features are atypical
• EEG findings are not characteristic
• Neurological examination is abnormal 1

When imaging is needed, MRI is superior to CT for detecting structural abnormalities (55% vs 18% detection rate in focal epilepsies) 1.

Structural Brain Differences (Research Context)

Recent neuroimaging studies reveal neurodevelopmental differences rather than epilepsy-induced damage:

• Cortical thickness variations in frontal and parietal lobes, predominantly in children under 10 years 8
• White matter differences in left superior longitudinal fasciculus 8
• These differences diminish with age and longer epilepsy duration, suggesting developmental delay rather than progressive damage 8

Treatment Options

First-Line Medication

Sulthiame (STM) is the first-line drug where available, with proven efficacy in controlling seizures in typical benign rolandic epilepsy 9.

Carbamazepine (CBZ) is the most commonly used alternative and is very effective 9, but carries a critical risk:

Major Treatment Pitfall

Carbamazepine can worsen clinical and EEG features, potentially precipitating continuous spike-wave during slow sleep (CSWS) in susceptible patients 9. This represents a serious atypical evolution requiring different management.

Treatment Decision Algorithm

1. Typical presentation with infrequent seizures: Consider observation without medication, given excellent prognosis and self-limited nature
2. Frequent seizures affecting quality of life:
   • First choice: Sulthiame (where available)
   • Alternative: Carbamazepine with close monitoring for atypical features
3. Atypical features or CSWS development: Steroids show best efficacy for cognitive dysfunction related to epileptic discharges 9

Prognosis and Atypical Evolution

Typical Course

• Spontaneous remission in adolescence 2
• 62-71% seizure-free by 2 years on medication 4
• Similar long-term outcomes between typical and atypical presentations 4
• Only 16% require trial of second antiepileptic drug 4

Risk Factors for Atypical Evolution

Early age at onset and frequent spike-wave discharges are risk factors for:

• Severe neuropsychological impairments 6
• Progression to CSWS 6
• Atypical benign focal epilepsy of childhood, status of Rolandic epilepsy, or Landau-Kleffner syndrome 6

These conditions represent a spectrum related to Rolandic epilepsy, likely reflecting genetically determined transitory developmental failure affecting the perisylvian communication network 7.

Monitoring Strategy

• Watch for emerging language difficulties, behavioral changes, or cognitive decline
• Repeat EEG if atypical features develop to assess for CSWS
• Recognize that comorbid disorders are slightly more frequent in atypical presentations but do not necessarily predict worse seizure outcomes 4